Alpine Bank Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Alpine Bank Wealth Management's BMY Position: Q2 2026 in Review
Alpine Bank Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.03% in Q2 2026, selling an estimated $172 and leaving 9,893 shares worth $570K. The position accounts for 0.07% of the portfolio, ranked #115.
Alpine Bank Wealth Management first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $678K in Q1 2025. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Alpine Bank Wealth Management held 9,893 shares of Bristol-Myers Squibb worth $570K as of Q2 2026.
- Alpine Bank Wealth Management sold 3 Bristol-Myers Squibb shares in Q2 2026, an estimated $172.
- Bristol-Myers Squibb made up 0.07% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #115 holding.
- Alpine Bank Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
- Alpine Bank Wealth Management's Bristol-Myers Squibb position peaked at $678K in Q1 2025.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.